Bioethics 25 (3):145-154 (2011)

Authors
Joseph Millum
University of St. Andrews
Abstract
ABSTRACTMany recent articles argue that participants who seroconvert during HIV prevention trials deserve treatment when they develop AIDS, and there is a general consensus that the participants in HIV/AIDS treatment trials should have continuing post‐trial access. As a result, the primary concern of many ethicists and activists has shifted from justifying an obligation to treat trial participants, to working out mechanisms through which treatment could be provided. In this paper I argue that this shift frequently conceals an important assumption: that if there is an obligation to supply treatment, then any party who could provide it may be prevailed upon to discharge the obligation. This assumption is false. The reasons why trial participants should get ART affect who has the duty to provide it. We should not burden governments with the obligations of sponsors, nor researchers with the obligations of the international community. And we should not deprive a group of treatment because their need is less salient than that of research participants. Insisting otherwise may lead to people being wrongfully deprived of access to antiretrovirals.
Keywords info:mesh/Anti-Retroviral Agents  info:mesh/Clinical Trials as Topic  info:mesh/Humans  info:mesh/Research Subjects  info:mesh/Health Services Accessibility  info:mesh/Bioethical Issues  info:mesh/HIV Infections  Humans   HIV Infections   Anti-Retroviral Agents   Bioethical Issues
Categories (categorize this paper)
DOI 10.1111/bioe.2011.25.issue-3
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Philosophical Expertise Beyond Intuitions.Anna Drożdżowicz - 2018 - Philosophical Psychology 31 (2):253-277.

View all 15 citations / Add more citations

Similar books and articles

Post-Trial Access to Treatment: Corporate Best Practices.Irene Schipper & Silvia Colona - 2015 - SOMO Centre for Research on Multinational Corporations.

Analytics

Added to PP index
2009-07-09

Total views
277 ( #35,836 of 2,462,264 )

Recent downloads (6 months)
56 ( #15,071 of 2,462,264 )

How can I increase my downloads?

Downloads

My notes